Published • loading... • Updated
J&J's Oral IL-23 Drug Backed for Psoriasis in EU
Summary by Pharmaphorum
3 Articles
3 Articles
The EMA recommends twelve new medicines for approval, including new therapies for high cholesterol levels, macular degeneration, psoriasis and Covid-19.
·Berlin, Germany
Read Full Article
The Committee for Medicinal Products for Human Use (Chmp) of the European Medicines Agency (EMA), meeting from 20 to 23 July 2026, recommended the approval of twelve new medicinal products and the extension of therapeutic indications for eight medicinal products already authorised in the European Union.
Coverage Details
Total News Sources3
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
